MindWalk Holdings Corp. HYFT

Healthcare SIC 2834 - Pharmaceutical Preparations NAICS Manufacturing › Chemical Manufacturing › Pharmaceutical and Medicine Manufacturing › Pharmaceutical Preparation Manufacturing derived Nasdaq

Last close —

Market cap —

52-week range — - —

No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.

Valuation FY2026 figures against the last close

P/S—

P/E—

P/FCF—

EV/EBITDA—

Dividend yield—

Diluted EPS—

Annual financial statements

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-312694.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)

Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity

Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks

No annual figures to plot for this company yet.

Others in SIC 2834

Ticker	Company	Market cap	P/E	Revenue growth
LLY	ELI LILLY & Co	$1.20T	55.5x	44.7%
JNJ	JOHNSON & JOHNSON	$635.76B	23.9x	6.0%
ABBV	AbbVie Inc.	$504.76B	121.0x	8.6%
MRK	Merck & Co., Inc.	$358.41B	20.0x	1.3%
ABT	ABBOTT LABORATORIES	$180.63B	27.9x	5.7%
PFE	PFIZER INC	$171.16B	22.1x	-1.6%
VRTX	VERTEX PHARMACEUTICALS INC / MA	$132.80B	34.2x	8.9%
BMY	BRISTOL MYERS SQUIBB CO	$125.59B	17.8x	-0.2%